Obesity Clinical Trial
— Implementa-MACOfficial title:
Implementation of the Brazilian Cardioprotective Diet in Primary Health Care: a Cluster Randomized Type II Hybrid Implementation Study
Verified date | December 2023 |
Source | Hospital do Coracao |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is an implementation type II hybrid study with randomisation in cluster, whose objective is to compare two strategies of implementation of the Brazilian cardioprotective diet guidelines in primary health care in two Brazilian cities. All health professionals from the health units (clusters) randomized to the intervention group will receive training on the subject. The health professionals from the health units randomized to the control group will follow the usual activities, receiving only the printed guidelines, as usually done. After 6 months, the prescription rate of the Brazilian cardioprotective diet will be evaluated, as well as the quality of the diet of patients in both groups.
Status | Completed |
Enrollment | 786 |
Est. completion date | December 19, 2023 |
Est. primary completion date | November 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Clusters Inclusion criteria: All Public Primary Care Units from both cities will be included. However, the Health services that encourage health professionals to use the Cardioprotective Food manual before randomization will be excluded. Participants (patients) Inclusion criteria: - Individuals aged =20 years of either sex who have a previous medical diagnosis of at least one of the following conditions: - Type 2 diabetes mellitus; - Systemic arterial hypertension (Systolic blood pressure =140 mmHg or diastolic blood pressure greater than =90 mmHg or in drug treatment for hypertension); - Isolated hypercholesterolemia: isolated increase in LDL-c (LDL-c = 160 mg/dL). - Isolated hypertriglyceridemia: isolated increase in triglycerides (TG = 150 mg/dL or = 175 mg/dL if the sample is obtained without fasting). - Obesity or overweight (body mass index =25.0 kg/m2). Exclusion Criteria: - Prior cardiovascular event (acute myocardial infarction, stroke, peripheral arterial disease); - Psychiatric or neurocognitive condition that prevents understanding of guidelines (defined by the clinical judgment of the investigators); - Life expectancy less than 6 months (example: metastatic malignant neoplasm) to be defined by the investigator's judgment; - Pregnancy or lactation; - Liver failure with a previous history of encephalopathy or anasarca; - Chronic renal failure; - Organ transplantation; - Gastroplasty for less than a year; - Impossibility of oral feeding. - No access to internet or mobile phone. |
Country | Name | City | State |
---|---|---|---|
Brazil | Prefeitura Municipal de Foz do Iguaçu | Foz do Iguaçu |
Lead Sponsor | Collaborator |
---|---|
Hospital do Coracao |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Brazilian cardioprotective diet prescription rate | Implementation Primary Outcome (rate of eligible individuals who received Brazilian cardioprotective diet prescription) | 6 months | |
Primary | food intake of 400g of vegetables per day | Eficacy Primary Outcome - number of patients that achieve the goal of eating 400g of vegetable/day | 6 months | |
Secondary | Implementing the extra dietaty guidelines | rate of eligible individuals who received extra dietaty guidelines | 6 months | |
Secondary | Professionals' understanding of the Brazilian cardioprotective diet | standardized questionnaire. Continuous result (number of correct answers) and dichotomous (good knowledge / poor knowledge) | right after intervention and 6 months after intervenions. | |
Secondary | Patients' understanding of the Brazilian cardioprotective diet | standardized questionnaire. Continuous result (number of correct answers) and dichotomous (good knowledge / poor knowledge) | right after intervention and 6 months after intervenions. | |
Secondary | Patients' adherence to dietary guidelines | Vigitel dietary indicators | right after intervention and 6 months after intervenions. | |
Secondary | Participants' weight | wheight in kg | right after intervention and 6 months after intervenions. | |
Secondary | Barriers and facilitators identified in the implementation of the Brasilian Cardioprotective diet in health facilities (situational diagnosis). | Qualitative metodology: Focus groups with stakeholdrs and professionals involved in the implementation processo to identify barriers and facilitators perceived by them | 6 months | |
Secondary | Professionals' perception regarding the incorporation of MAC guidelines into practice (implementation component) | standardized questionnaire. Dichotomus result (Agree/Disagree with the incorporation) | right after intervention and 6 months after intervenions. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |